| __timestamp | Amgen Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 4297000000 | 382096000000 |
| Thursday, January 1, 2015 | 4070000000 | 345927000000 |
| Friday, January 1, 2016 | 3840000000 | 312303000000 |
| Sunday, January 1, 2017 | 3562000000 | 325441000000 |
| Monday, January 1, 2018 | 3737000000 | 368298000000 |
| Tuesday, January 1, 2019 | 4116000000 | 492381000000 |
| Wednesday, January 1, 2020 | 4207000000 | 455833000000 |
| Friday, January 1, 2021 | 4819000000 | 526087000000 |
| Saturday, January 1, 2022 | 4434000000 | 633325000000 |
| Sunday, January 1, 2023 | 4784000000 | 729924000000 |
| Monday, January 1, 2024 | 5964000000 | 729924000000 |
Cracking the code
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) investment is a key driver of innovation. Over the past decade, Amgen Inc. and Takeda Pharmaceutical Company Limited have demonstrated contrasting strategies in their R&D expenditures. From 2014 to 2023, Takeda's R&D spending surged by approximately 91%, reflecting its aggressive pursuit of new therapies and market expansion. In contrast, Amgen's investment grew by about 11%, indicating a more steady approach.
Takeda's R&D expenses peaked in 2023, reaching nearly 730 billion yen, a testament to its commitment to innovation. Meanwhile, Amgen's highest expenditure was in 2021, with a notable 4.8 billion dollars. This disparity highlights the different scales and strategies of these pharmaceutical giants. As we look to the future, the impact of these investments will shape the next wave of medical breakthroughs.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Research and Development Expenses Breakdown: Amgen Inc. vs Genmab A/S
Research and Development Expenses Breakdown: Amgen Inc. vs Madrigal Pharmaceuticals, Inc.
Amgen Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and BeiGene, Ltd.
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
Takeda Pharmaceutical Company Limited or Grifols, S.A.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and MorphoSys AG
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and Agios Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Takeda Pharmaceutical Company Limited and Dynavax Technologies Corporation
Comparing Innovation Spending: Takeda Pharmaceutical Company Limited and MiMedx Group, Inc.